Kaliumchlorid Noridem (Potassium Chloride)

Kaliumchlorid Noridem is used to correct potassium deficits and restore electrolyte balance in clinical settings.

• Hypokalemia: restores normal serum potassium levels in patients with low potassium.
• Potassium depletion: replenishes potassium stores after losses due to diuretics, gastrointestinal loss, or surgery.
• Electrolyte replacement: provides a rapid intravenous source of potassium during acute care or peri‑operative management.

• Potassium chloride dissociates after intravenous administration, releasing potassium ions that enter the extracellular fluid. The increased extracellular potassium raises serum potassium concentration, helping to re‑establish the normal transmembrane gradient, stabilize cardiac myocyte resting potential, and support proper neuromuscular function.

Kaliumchlorid Noridem may cause adverse reactions ranging from mild to severe.

Common Side Effects

• Injection site pain: discomfort or tenderness at the infusion site.
• Nausea: mild gastrointestinal upset following administration.
• Dizziness or headache: transient sensations of light‑headedness.

Serious or Rare Side Effects

• Severe hyperkalemia: dangerously high serum potassium leading to cardiac arrhythmia.
• Anaphylactic reaction: rare hypersensitivity with rash, swelling, or respiratory distress.
• Venous thrombosis: clot formation at the infusion site.

Use Kaliumchlorid Noridem with careful clinical monitoring to avoid complications.

• Serum potassium monitoring: check levels before, during, and after infusion.
• Renal impairment: adjust infusion rate or dose in patients with reduced kidney function.
• Cardiac disease: avoid rapid infusion in patients with known arrhythmias.
• Concomitant potassium‑sparing agents: limit total potassium load.
• Infusion rate: administer over the recommended time to prevent sudden shifts.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium chloride can interact with several medications that affect potassium balance.

Major Interactions (Avoid)

• ACE inhibitors or ARBs: may cause additive hyperkalemia.
• Potassium‑sparing diuretics (e.g., spironolactone): increase risk of excessive potassium.
• NSAIDs: can reduce renal potassium excretion.
• Trimethoprim: potentiates hyperkalemia.
• Cyclosporine: may impair potassium handling.

Moderate Interactions (Monitor Closely)

• Digoxin: hyperkalemia can enhance digoxin toxicity.
• Beta‑blockers: monitor cardiac function with elevated potassium.
• Insulin therapy: insulin shifts potassium intracellularly; monitor levels.
• Other IV fluids containing potassium: avoid cumulative excess.
• Corticosteroids: may alter electrolyte balance, requiring observation.